Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union

<table>Responses to the following question: How do you feel about a statement on RSV palivizumab use in guidelines/protocols for management of children with DS? The responses are shown in relation to each other. </table>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union 